Clinical practice guidelines provide evidence-based recommendations. However, many problems are reported, such as contradictions and inconsistencies. For example, guidelines recommend sulfamethoxazole/trimethoprim in child sinusitis, but they also state that there is a high bacteria resistance in this context. In this paper, we propose a method for the semi-automatic detection of inconsistencies in guidelines using preference learning, and we apply this method to antibiotherapy in primary care. The preference model was learned from the recommendations and from a knowledge base describing the domain.
Introduction
In the 1990s, the concept of Evidence-Based Medicine was introduced and defined as "the integration of best research evidence with clinical expertise and patient values" [1] . This new paradigm led to the redaction and diffusion of Clinical Practice Guidelines (CPGs) by national health authorities [2] . CPGs are narrative documents providing recommendations stated by a group of experts according to a systematic review of the available clinical evidence. They aim at improving the quality of health care by providing standardized best practices for diagnosis and treatment. Their development is complex and requires time, rigor and multiple verification and validation steps to guarantee their quality [3, 4, 5, 6] . However, many problems are reported like incompleteness, contradiction, inconsistency, redundancy or ambiguity within CPGs [4] . This leads to a lack of confidence of physicians in CPGs [7] , and thus a poor consideration of CPG recommendations in their daily routine clinical practice [8] .
For verifying the quality of recommendations within CPGs, various methods were developed. The structure of CPGs can be verified by tools [9, 10] such as AGREE instrument [11] . These tools focus on quality criteria, e.g. presentation of guidelines, or independence of experts [12] . However, these methods are limited to the verification of the structure of CPGs, and do not consider the consistency and medical pertinence of recommendations.
The consistency of recommendations can be verified by formal methods [13] . The recommendations are first represented using an explicit and non-ambiguous model in a formal language. Several Computed Interpretable Guidelines (CIG) were developed [14] .
They allow detecting ambiguity, incompleteness, inconsistency or redundancy within CPGs [6, 15, 13, 3, 16, 17] . For example, some authors [18, 19] state that, if narrative guidelines are encoded into logical language ("if... then..." rules), then the generation of all possible variable combinations allows the detection of incompleteness (i.e. variable combinations not covered by CPGs) and inconsistencies (i.e. similar variable combinations leading to different conclusions). But these methods are time-consuming and dependent on the formal language. Moreover, these formal approaches don't verify the medical pertinence (e.g. they do not verify that the recommended drug treatments are not contraindicated for the patient).
Few approaches have been proposed for verifying the medical pertinence of recommendations. These approaches require the formalization of the medical knowledge involved (e.g. drug properties such as contraindications) and the identification of the medical principles underlying the recommendations of CPGs. However, formalizing the knowledge and the reasoning principles is a complex task [13] . For example, in oncology, a medical domain where multiple drugs are often prescribed, the adverse events can be limited by checking the known adverse effects [20] .
Recently, many approaches have been proposed for enriching recommendation by integrating additional information. These pieces of information concern particularly patient context (psycho-social, multi morbidity, etc.) and patient preferences [21, 22, 23, 24, 25, 26] . For example, in multi-criteria decision making, to recommend an appropriate manual wheelchair, user preferences that are often conflicting must be taken into account [27] . Nevertheless, the manual construction of preferences remains complex and time-consuming. Thus, it is more appealing to learn preferences from data, because in general, data are easily collected or observed.
In this article, we propose a method for the semi-automatic detection of inconsistencies in guidelines using preference learning, and we apply this method to antibiotherapy in primary care. In primary care, CPGs recommend prescribing antibiotics empiri-
Input Objective
Label ranking A set of instances X = {x i |i = 1 . . . n}. A set of labels L = {l k |k = 1 . . . m}. For each instance x i , a set of pairwise preferences of the form l k x i l j .
Find a ranking function that maps any x ∈ X to a ranking x ∈ L.
Instance ranking
A set of instances X = {x i |i = 1 . . . n}. A set of ordered labels L = {l k |k = 1 . . . m} such that:
Find a ranking function that allows to order a new set of instances according to their (unknown) preference degrees.
Object ranking
A set of objects X = {x i |i = 1 . . . n}.
A finite set of pairwise preferences x i x j .
Find a ranking function that assumes as input a set of objects and returns a permutation (ranking) of this set. cally, i.e. without knowing the causative bacteria and its susceptibility to the various antibiotics. The most likely bacteria are guessed from the infectious disease (e.g. cystitis is usually caused by E. coli). Then, CPGs recommend an antibiotic according to the various antibiotics features (e.g. susceptibility of the likely causative bacteria, side effects) and the patient profile (e.g. child or adult) [28, 29] . In order to detect inconsistencies in these CPGs, we made the following hypotheses: 1) it is possible to learn a preference model from the recommendations and a knowledge base describing the domain; 2) a generic model can be defined for all infectious diseases and all patient profiles encountered in CPGs; and 3) this preference model can be used to detect inconsistencies in CPGs.
The rest of the paper is organized as follows. Section 2 gives background about preference learning, and describes the optimization algorithm we used and the antibiotherapy knowledge base we previously designed. Section 3 describes the preference learning. Section 4 describes the detection of inconsistencies and their validation by a medical expert. Section 5 discusses the methods and the results obtained, and finally, concludes.
Background

State of the art in preference learning
Preferences are basically acquired in two ways: i) by elicitation from the user (for instance through a sequence of queries/answers) or ii) by directly learning them from data. Preference elicitation is often time-consuming, especially if the number of alternatives/outcomes is large. Moreover, different elicitation techniques are likely to provide different results. It is then more appealing to learn preference from data which is easy to observe and collect. Preference learning is one of the research problems that have recently received considerable attention in disciplines such as artificial intelligence, machine learning, data mining, decision making and others. It aims to learn and construct a preference model from observed preference information. Once the preference model learned, it can be used for decision making for instance. Preference learning can be formalized within various settings, depending for example on the underlying preference model and the type of input provided to the learning system. We can distinguish three common problems in preference learning [30] : i) learning from label preferences (also designed as label ranking in the literature because frequently, the predicted preference relation is required to form a total order), ii) learning from instance preferences (instance ranking) and iii) learning from object preferences (object ranking). Table 1 summarizes the different ranking problems.
In label preferences problem [31, 32] , the training data contains a set of instances. A set of pairwise comparisons between labels is associated with each instance, expressing that one label is preferred over another for that instance. The objective is to use these pairwise preferences for predicting a ranking function that attributes for any instance a ranking (a total order in general) of all possible labels. Namely, the task is to rank the set of labels for a new instance (label ranking). Label ranking can be considered as a generalization of the supervised classification problem where an order over class labels is associated with an instance instead of only one class label. As an example of a label ranking problem, consider a set of labels L representing three types of activities: football, tennis and basket. The training data contains a set of students who have to give a list of pairwise preferences between activities (e.g. {(Adrien, [ f ootball tennis]), (Marie, [tennis f ootball]}). Thus, the aim is to compute a ranking over the labels for each instance. For example, the possible prediction of the learnt function for a student x is football basket tennis.
In the setting of learning from instance preferences problem [33] , the input contains a set of ordered labels and a set of instances, each one associated with a label. The objective is to find a ranking function that allows ranking a given new set of instances. In case where there are two ordered labels, the problem of learning is often called bipartite ranking problem [34] . In case where there are more than two ordered labels, the problem of learning is often called multipartite-ranking problem [35] .
Concerning learning from objects [36, 37] , the objective is to learn a model that allows determining which object is preferred to another. The training data is given in the form of pairwise comparisons between objects. For this type of learning problems, there is no supervision since no class label is associated with an object and each object is not necessarily represented by a set of features or attributes. As an example, to rank query results of a search engine, user clicks on some of the links in the query result and not on others can be exploited to provide training information. Thus, selected pages are preferred over pages that are not clicked.
Two approaches can be distinguished for preference modeling and learning: quantitative and qualitative approaches. Quantitative preferences learning [38, 39] consist mainly to learn a utility function on training data. This function assigns a utility degree (or a score) to each alternative (instance, object or label) following the learning problem. For learning problems that are based on qualitative approach [40, 41, 42, 43, 44] , the objective is to learn a binary preference relation that compares each pairs of alternatives.
When it comes to modeling utility functions, the task is rather more complicated since users may not be used with this formal-ism and the problem size could be very large. Utility functions (for example, the one a user is supposed to use while making decisions) can be inferred or estimated from past decisions. In [45] , this problem is solved by imposing constraints derived from the data over the set of all utility functions. One could go one step further by searching for the optimal utility function given the available constraints. Among first works dealing with deriving utility functions from data, one can mention [46] where the authors aim at extracting reward functions given optimal behaviors in the context of Markov Decision Processes. The main issues dealt with the literature last years concern noise and data inconsistencies and uncertainty, large search spaces and taking into account data sequence, etc. In [47] , the authors proposed an approach to learn utility functions allowing to monitor requirements of a dynamically adaptive system. The learned utility functions map at run time monitoring information to a value assessing how well a requirement is satisfied.
Once the preferred model is learned, there is need to measure its quality of prediction. For this, different performance measures can be used such as precision, recall, NDCG (Normalized Discounted Cumulative Gain), etc. In addition, preference learning methods require optimization algorithms. In this study, we will use the Artificial Feeding Birds (AFB) metaheuristics [48, 49] . We developed this metaheuristics in previous works, and we describe it in the following section.
Artificial Feeding Birds (AFB) metaheuristics
Nature-inspired metaheuristics [50, 51] are an optimization approach, which often leads to simple, efficient and adaptable algorithms. In this work, we chose Artificial Feeding Birds (AFB) [48, 49] , a recent metaheuristic inspired by the behavior of pigeons.
AFB considers a population of artificial birds. The position of a bird corresponds to a candidate solution to the optimization problem. The optimization process aims at minimizing the cost() function, (i.e. finding x such as cost(x) is as low as possible). The value returned by the cost() function is associated with the presence of food: if the value of the cost() function for the new position of a bird is lower than his previous lowest value, the bird has found some food and he keeps his current position in memory.
In each iteration of the algorithm, each bird performs a move. Four possible moves are considered: (1) the bird walks to a close random position, (2) the bird flies to a completely random position, (3) the bird flies back to the best position he has encountered so far, and (4) the bird flies to join the position of another random bird. For a given bird, the next move is determined as follows: if the bird has flown in the previous cycle, he walks. If the bird has found a better solution in the previous cycle, he walks. Otherwise, the next move is chosen randomly, with different probabilities associated with each move. Two sizes of birds are considered, and the fourth move (join another bird) can only be performed by the largest birds (representing 25% of the population).
The optimization problem is defined by three functions: cost(), the function to minimize, f ly(), a function that returns a random position in the solution space, and walk(i), a function that modifies the current position of the bird i by performing a small random move.
The metaheuristic takes 5 parameters: -n = 20, the number of artificial birds, -r = 0.75, the ratio of small birds in the total bird population, -p 2 = 0.01, the probability that a bird chooses move 2, -p 3 = 0.67, the probability that a bird chooses move 3, -p 4 = 0.07, the probability that a bird chooses move 4. The parameter values given here are the ones we used; they correspond to the default values proposed in [49] . The AFB algorithm is known to have a low sensitivity to parameter values, and these values were successfully used in very different optimization problems (non-linear global optimization on benchmark functions, neural network training, combinatorial optimization). The metaheuristics algorithm is given in Supplementary File 1.
Antibiotherapy knowledge base
In previous works [28, 29] , we designed an antibiotherapy knowledge base for helping physicians with empirical prescription of antibiotics. The knowledge base contains information related to 11 infectious diseases, the 50 antibiotics marketed for use in primary care in France, and 21 patient profiles. Figure 1 shows the general model of the knowledge base. Infectious diseases are associated with the likely causative bacteria (one or several; several types of bacteria can cause the same disease). A patient profile is described by the age class and the presence or absence of pregnancy, allergy, and history of antibiotic treatment. A clinical situation corresponds to the intersection of an infectious disease and a patient profile. Finally, a given antibiotic prescribed for a given clinical situation is called a case in the knowledge base. It is the lowest granularity level in the knowledge base. Each case has an integer recommendation rank, which is 0 if the antibiotic is not recommended by French CPGs in the clinical situation, 1 if it is recommended as a first-line treatment, 2 if it is recommended as a second-line treatment, and so on (up to 4).
In addition, cases are characterized by 11 features (listed in Table 2). In the paper, each feature is identified by a short name, such as protocol. For a given feature, the value may depend on the antibiotic, the patient profile, the infectious disease and/or the likely causative bacteria. For example, no side e f depends only on the antibiotic, whereas no contraindication depends on the antibiotic and the patient profile (e.g. a given antibiotic may be contraindicated for children but not for adults). Each feature is Boolean (T rue if the feature holds for the case and False otherwise), with possible missing values (Unknown) when no data is available in the medical literature. For each feature, T rue corresponds to an advantage for the antibiotic, whereas False is a disadvantage.
The knowledge base was built and populated by a medical doctor (RT) through a 2 steps-process. In step 1, RT extracted the features of antibiotics and their dependence relationships [28, 29] , from the manual analysis of six CPGs related to urinary [52, 53] and respiratory [54, 55, 56, 57] Whether the antibiotic has an acceptable taste for the patient (e.g. Cefuroxime axetil has a bad taste and thus is not acceptable for children) X X of existing antibiotic knowledge base able to describe the features identified in step 1, only textual resources were used to populate the knowledge base. RT manually extracted the values for each feature (i.e. T rue, False, or Unknown) from seven French CPGs [52, 53, 54, 55, 56, 58, 59] , two international CPGs [60, 61] , five antibiotic guidelines produced by national authorities [62, 63, 64, 65, 66] , and one reference textbook on infectious diseases [67] . For example, for fosfocmycin trometamol in women cystitis, protocol = T rue was extracted from the following CPG excerpt [53] : "Fosfomycin trometamol is recommended in women cystitis because it can be given in single dose". 3. Building the preference model Figure 1) . Building a preference model from the case features and the recommendations of CPGs is an instance learning problem (as described in section 2.1). In the knowledge base, there are 5 recommendation ranks: recommended as 1 st , 2 nd , 3 rd , 4 th line of treatment (R 1 , R 2 , R 3 , R 4 , respectively) or not recommended (NR), which correspond to 5 labels that are ordered (R 1 R 2 R 3 R 4 NR). There are 102 cases labeled R 1 , 62 labeled R 2 , 30 labeled R 3 , 2 labeled R 4 and 3104 labeled NR. Since there are very few cases having the R 3 and R 4 labels, for facilitating the learning of preferences, we divide this multipartite-ranking problem in two bipartite ranking problems. In the first problem, we consider the two following labels: R 1 vs R 2 ∪ R 3 ∪ R 4 ∪ NR (i.e. all cases not recommended as first-line treatment are grouped together). In the second problem, the labels are: R 1 ∪R 2 ∪R 3 ∪R 4 vs NR (i.e. all cases recommended are grouped together whatever their recommendation rank). Thus, we will learn two different preference models, respectively named M 1 and M any , one for each problem. The two models will be learned following the same method, described below.
Modeling the knowledge base
We model the antibiotic knowledge base as a case space X = {x 1 , ... 2 AL: attribute language (including atomic negation, concept intersection, universal restriction, existential qualification limited to class Thing), C: complex negation, (D): use of datatypes [68] . Table 4 : Results of the learning process on the example of Table 3 . Table 3 shows the structure of the knowledge base on a simplified example with only 5 antibiotics, 2 clinical situations, p = 3 features and n = 10 cases.
Feature
N j w j Category no contraindication 0% -Necessary no side e f 50% 0.2 Preference protocol 25% 0.3 t ness 10% Threshold t pre f 0.5
Determining necessary and preference features
We make the hypothesis that two categories of features exist: necessary features and preference features. Necessary features are mandatory for prescribing the antibiotic: if the feature does not hold for an antibiotic in a clinical situation, the antibiotic should not be prescribed and thus it is not recommended (necessary features can be viewed as constraints). On the contrary, preference features are not mandatory; however, an antibiotic having a preference feature is preferred to another antibiotic without the preference feature. For example, the absence of contraindications may be a necessary feature while the low rate of adverse effects may be a preference feature.
In order to learn which features are necessary, for each feature j (with 1 ≤ j ≤ p) we compute N j , the percentage of recommended cases for which the feature j is not necessary to recommend the antibiotic, i.e. feature j is not True but the antibiotic is nevertheless recommended in guidelines: Table 4 shows the computed values for N j on the simplified example of Table 3 . In an "ideal" error-less system, a necessary feature has N j = 0 (e.g. feature no contraindication in the example). In real life, there may be a few errors. Thus, we consider as necessary all features j having N j ≤ t ness , where t ness is a threshold that will be learned later. We define F ness and F pre f , the sets of necessary and preference features, respectively (each feature being identified by its index).
In the example (Table 4) , the learning process leads to t ness = 10%. This means that no contraindication is a necessary feature, whereas protocol and no side e f are preference features.
Defining the utility function
For preference features, we define a utility function f : X → R that allows ordering cases according to their degree of preference, i.e. f (x i ) ≥ f (x j ) ⇒ x i x j . We define f as a linear combination of the preference features:
The weights w j will be learned later. The utility function quantifies the utility of an antibiotic in a clinical situation. However, the utility is meaningless per se, and it can only be exploited relatively to the utility of other antibiotics. For example, an antibiotic with a low utility could be recommended if no better antibiotic exists in a given clinical situation. Moreover, the antibiotics recommended may not be limited to the one with the best utility: other antibiotics with a high utility, but slightly lower than the best one, might be considered as recommended too. Consequently, in a given clinical situation, we consider as recommended all antibiotics having a utility highest to the best utility found in this clinical situation minus t pre f , a second threshold that must be learned.
In the example, Table 4 shows the learned weights and thresholds. The resulting f (x i ) are given in the right part of Table 5 . For example, for case x 4 , f (x 4 ) = False × 0.2 + T rue × 0.3 = 0.1 (we remind that False = −1 and T rue = 1).
Determining antibiotics recommended by the preference model
For each clinical situation S k ∈ S, the antibiotics recommended by the preference model can be determined in three steps. First, we compute S k cand , the set of candidate cases that can be prescribed with regards to necessary features:
If S k cand = ∅, no antibiotic is recommended by the preference model and the process stops here.
Second, we determine x best , the case ranked the highest by the utility function:
Third, we compute S k reco , the set of cases classified as recommended, and including all candidate cases from S k cand for which the utility function is higher than (or equal to) the best value found previously minus the threshold t pre f :
In the example, the right part of Table 5 indicates which cases belong to S k cand and S k reco . The example has two clinical situations X and Y. There is a best utility value f (x best ) for each clinical situation (shown in bold in Table 5 ). Then, for each clinical situation, we determine recommended cases using formula 7. For example, in situation X, x 4 has the best utility, and is therefore recommended. x 3 has a lower utility than x 4 , but not lower than the utility x 4 minus t pre f = 0.5. Thus, x 3 is recommended too. On the contrary, x 2 has a utility lower than the utility x 4 minus t pre f = 0.5, and therefore is not recommended. 
Optimizing weights and thresholds
In order to learn necessary features and preferences, we need to find the optimal values for the weights w 1 , ..., w p and the two thresholds t ness and t pre f .
The values of weights and thresholds were searched between 0 (the feature has no importance at all) and 1 (the feature has the maximal importance). The optimal weights and thresholds should minimize the total number of errors E, i.e. the number of recommended cases classified as non-recommended (false negatives) and the number of nonrecommended cases classified as recommended (false positive) by the preference model:
where z is a coefficient that allows giving more importance to either type of errors (false negatives or false positives). By changing the value of z, it is possible to obtain different results in terms of precision and recall, and to produce the PR curve (precisionrecall).
This is an unconstrained global non-linear optimization problem with a solution space of p + 2 dimensions. We used the Artificial Feeding Birds (AFB) metaheuristics [48, 49] for solving the problem. The system has been implemented in Python 3 and executed with PyPy 3, a Python interpreter that includes a JIT (Just-In-Time) compiler. The cases were extracted from the OWL ontology. We used two open source Python module: Owlready for ontology-oriented programming [69] , and Metaheuristic_Optimizer for optimization with AFB. Figure 2 shows the PR curve. For the rest of the analysis, we fixed z to 1 (i.e. both types of errors have the same weight). We performed 20 runs of the optimization program and we stopped it after 15,000 solutions were tested. We kept the best result found. For M 1 , we obtained E = 50 (14 false positives and 36 false negatives), leading to a sensitivity/recall of 64.7%, a precision of 82.5%, and a specificity of 99.6%. For M any , we obtained E = 82 (32 false positives and 50 false negatives), leading to a sensitivity/recall of 75.5%, a precision of 82.0%, and a specificity of 99.0% (corresponding to the dots on the PR curve). t ness = 15% t pre f = 0.015 t ness = 20% t pre f = 0.77 Table 6 : Results of the learning process (N j , learned weights and thresholds, for z = 1) for the two preference models M 1 and M any . Table 6 shows the results of the learning process, for z = 1, for the two preference models M 1 and M any (i.e. considering only cases recommended as first-line treatment or as any line of treatment, see section 3.1). 4 necessary features are found in both models: naturally active, probably active, proved and no contraindication. The seven others are preference features. For determining the first-line treatments (R 1 with model M 1 ), the most important preference features are not precious, taste and no side e f . On the contrary, for determining treatments that are recommended in any ranks (R 1 ∪ R 2 ∪ R 3 ∪ R 4 with model M any ), the most important preference features are taste and protocol. Indeed, taste is more important than what we may expect, because many clinical situations involve children and children refuse to take drugs with a bad taste. Two features, e f f icacy level and spect, have no impact for determining the first-line treatments and a very low impact for determining the recommended treatments in any ranks.
Detection of inconsistencies in CPGs
Methods
The 106 errors obtained during preference learning can be seen as candidate inconsistencies in CPGs: for those cases, the recommendation of the CPGs does not match the result obtained using the preference model we built from the whole guideline recommendations. Therefore, our hypothesis is that there might be inconsistencies in the CPGs for those cases.
All these candidate inconsistencies were manually verified by a medical expert (RT). For each candidate, the inconsistency was confirmed if the medical expert retrieved arguments within CPGs in contradiction with the level of recommendation given in CPGs. If no contradictions were found within CPGs, then the medical expert searched for contradictions in the argumentation of other guidelines (e.g. previously published CPGs, CPGs from other countries). Then the medical expert categorized the inconsistencies into various groups.
An example of contradiction follows. The CPG [70] says "the proof of efficacy of fosfomycin in cystitis with risk of complication (including pregnancy) is not sufficient", but, surprisingly, the CPG nevertheless recommends fosfomycin for the treatment of cystitis in pregnant women. Table 7 summarizes the various categories of candidate inconsistencies obtained from preference learning and the number of cases in each category. The expert validated 51.9% (55/106) of the candidates as inconsistencies in CPGs. The medical expert detected 29 contradictions related to the features probably active, 11 to proved, 9 to no contraindication, 4 to spect, and 2 related to a mix of several preference features.
Medical analysis of the candidate inconsistencies
Two categories of contradictions were distinguished:
(1) For 40 cases, CPGs recommend an antibiotic whereas there are arguments in the same or another CPG for not recommending this antibiotic. For example, the CPG [57] recommends sulfamethoxazole/trimethoprim in child sinusitis, but the CPG also states "because of the evolution of frequency of acquired resistance, sulfamethoxazole/trimethoprim is not recommended in sinusitis". Table 7 : Categorization of the candidate inconsistencies obtained from preference learning. (*) The "total" column is not the sum of the two previous columns, because 26 inconsistencies were discovered twice, once with the M 1 model and once with the M any model.
(2) For 15 cases, CPGs do not recommend a given antibiotic, whereas there are arguments in the same or another CPG for recommending this antibiotic in similar clinical situation. For example, in otitis with conjunctivitis, CPG [57] do not recommend amoxicillin and prefers the combination of amoxicillin/clavulanic acid; this choice is justified as follows: "Amoxicillin/clavulanic acid should be preferred because of a strong suspicion of H. influenzae infection". On the contrary, in otitis without conjunctivitis, CPG [57] recommends amoxicillin rather than the amoxicillin/clavulanic acid combination and justifies this choice as follows: "Amoxicillin should be preferred because (. . . ) it is active against H. influenzae strains".
The expert classified 16.0% (17/106) of the candidate inconsistencies as caused by flaws in the antibiotic knowledge base. Three categories of flaws were distinguished:
(1) For 9 cases, CPGs consider additional features that were missing in the knowledge base: bioavailability (i.e. antibiotic oral absorption), minimum inhibitory concentration (i.e. the lowest antibiotic concentration which prevents the growth of bacterium), and marketing authorization. For example, the preference model recommends levofloxacin in uncomplicated cystitis in women, but the argumentation of CPG [70] says " levofloxacin is not recommended because it does not have the marketing authorization" for this clinical situation in France.
(2) For 7 cases, the coding of features as Boolean is not precise enough. The two features involved are no side e f and not precious. For these cases, a more fine-grained gradation in at least three levels (e.g. none/moderate/high) is required. For example, the preference model recommends pristinamycin and telithromycin for pneumonia in children over the age of 12 years with betalactam allergy. Pristinamycin is recommended in CPG, but not telithromycin [54] . The argumentation of guidelines says that both may cause side effects, but telithromycin is associated with side effects more serious than pristinamycin. This information is missing in the knowledge base because values are coded as Boolean.
(3) For 1 case, the antibiotic recommended by the preference model is not marketed any more. The antibiotic should be removed from the knowledge base.
The expert classified 15.1% (16/106) of the candidate inconsistencies as caused by flaws in the preference model. Two categories of flaws were distinguished:
(1) For 7 cases, additional principles not considered in the model seemed to be used in CPGs. Two such principles were identified: (a) When several antibiotics are recommended, CPGs often propose antibiotics belonging to different therapeutic classes, because some patients have drug class allergy (e.g. penicillin allergy), and thus it is better to propose a wide variety of drug classes. (b) In a very few number of cases where no antibiotics have the necessary features, CPGs recommend some antibiotics without one of the necessary features (probably active).
(2) For 9 cases, the preference model seems different for children than from adult patient, whereas we hypothesized that a generic model exists for all patients and diseases (hypothesis #2 in introduction). More specifically, for these 9 cases, CPGs give more importance to side effects for children. For example: In adult sinusitis, CPGs recommends pristinamycin whereas in child, CPG [57] says "pristinamycin is not recommended because of the risk of side effects". However, no side effect specific to children (e.g. developmental disorders) were mentioned.
Finally, 17.0% (18/106) of the candidate inconsistencies could not be categorized by the medical expert.
Discussion and conclusion
In this paper, we showed that strategies followed by CPGs for establishing therapeutic recommendations in antibiotherapy can be formalized by a preference model. This model can be learned from the CPGs and a knowledge base describing the domain. In addition, the model allowed the detection of 106 candidate inconsistencies in CPGs, 55 of which were then validated by a medical expert. We also identified several flaws in the knowledge base. To the best of our knowledge, this is the first study that proposes using preference learning on drug properties for detecting inconsistencies within CPGs.
Discussion on the preference model and the learning process
Our preference model is based on a quantitative approach. It uses a simple utility function, which has the interest of producing results easily understandable by medical experts and physicians. In addition, the method we proposed allowed the learning of a single model from several clinical situations, each situation including several cases, and the various features can depend on the antibiotic, the patient profile, the infectious disease and/or the causative bacteria. As a consequence, the feature values can be assigned at various levels in the knowledge base. We used a formal ontology in OWL 2.0 for managing the knowledge base and for obtaining the feature values for each case, using inheritance. Despite the specificity of each infectious disease and patient profile, we successfully built a generic model satisfying all clinical situations described in CPGs, with the exception of 9 cases related to children.
Our utility function does not consider interactions between features, while in antibiotherapy, there might be some interactions. For example, two features a and b might have an impact on the utility, while the impact of a ∪ b is not the sum of the impact of a and b alone. More sophisticated methods, such as Choquet integral [71] , can capture the dependencies between features. In the future, we will aim to study this point.
The proposed method is interesting since it allowed learning not only preferences, but also necessary features (i.e. constraints) that are very important in preference reasoning. In the literature, few models exist that permit modeling both constraints and preferences [72] . For example, let us consider an antibiotic having protocol feature True but no contradiction False. If the learned preference model considers only preference features (e.g. no contradiction is preferred to protocol) as in most proposed learning preferences methods, then it is possible to recommend this antibiotic. However, in our proposed model, it cannot be recommended since the model contains also necessary features or constraints (such as no contradiction) which can be viewed as a propositional formula. For optimizing weights and thresholds, we reused the AFB metaheuristics. We chose metaheuristics in general because they are known to adapt quite well to many kinds of problems, whatever the size of the solution space is. Furthermore, in the literature, metaheuristics have already been used for preference learning [73] . AFB was chosen since it results from our previous works, and because it was found to be especially adaptable, and quite independent from parameter values.
AFB seems efficient for the problem presented here. We compared it with two other metaheuristics, Artificial Bee Colony (ABC) [74] and Firefly Algorithm (FA) [75] , for the learning of the M any model with z = 1. We performed 20 runs for each algorithm. For each run, the optimization process was stopped after 15,000 solutions were tested. Table 8 shows the mean results for each algorithm. AFB yielded the best results, and found the lowest value (82.0) in 7 runs. ABC found the lowest value in only 2 runs. On the contrary, FA never found the lowest value. Therefore, AFB seems an interesting algorithm for preference learning.
We used the default parameter values for AFB. We performed parameter optimization a posteriori, and we obtained better results with slightly different values: p 2 = 0.0049, p 3 = 0.78 and p 4 = 0.068. With those values, the mean result was 82.9 (instead of 83.6), and the best result was obtained 11 times out of 20 runs (instead of 7 times). However, the parameter optimization took half a day, thus it may not worth the time to perform it since the gain is low. This confirms previous results suggesting that AFB has a low sensitivity to parameter values.
Medical discussion of results
The learning process allowed the identification of two types of features: necessary vs preference. This confirms the results of previous works based on the manual analysis of CPGs [28, 29] . The distinction between necessary and preference features allows classifying antibiotics in 3 categories, for a given clinical situation: (1) the inappropriate antibiotics that should never be prescribed because they are not efficient for treating the infectious disease or they cannot be used for a given patient (i.e. antibiotics not having the necessary features), (2) the appropriate antibiotics that could be prescribed, but that are not the ones recommended because better antibiotics exist (i.e. antibiotics having the necessary features, but not preferred), and (3) the recommended antibiotics (i.e. antibiotics having the necessary features, and preferred). This classification into 3 categories could be helpful in clinical practice.
In addition, the learning process identified the weight of antibiotic features. Not surprising, the feature protocol has an important weight. Indeed, in clinical practice, physicians often prefer to prescribe drugs with short treatment duration and/or single daily dose to increase patient observance. The feature not precious has also an important weight for antibiotic recommended in first line (model M 1 ). This feature is specific to antibiotherapy where the objective is to rationalize the use of antibiotics because of bacteria resistance. Thus, some antibiotics are "preserved", and their use is restricted to specific clinical situations. The weight of the feature no side e f may seem lower than what we may expect. However, this can be explained because infectious diseases often require short treatments (one to 7 days), and thus the probability to develop side effects is lower than for longer treatments. Surprisingly, the features spect and low eco risk have a low weight. Since a current French campaign [76] encourages the use of antibiotics with narrow spectrum and low ecological risk, we expected higher weights for these features.
The preference learning on the antibiotic knowledge base allowed the detection of 106 errors. The analysis of these errors by a medical expert leads to the identification of 55 inconsistencies in CPGs (defined as contradictions between arguments retrieved in CPGs and the level of recommendation given in CPGs). Therefore, about half of the candidate inconsistencies were manually validated as inconsistencies in the CPGs. These inconsistencies could correspond to two subcategories: (i) either the level of recommendation given in CPGs is correct, but the arguments retrieved in CPGs are in contradiction, or (ii) the arguments retrieved in CPGs are correct, but the level of recommendation given in CPGs is in contradiction. Distinguishing between those two subcategories would require to gather all the experts who wrote the CPGs, which is hardly feasible.
Perspectives
In the future, we will aim at improving our approach in various ways. The missing antibiotic features (e.g. bioavailability) and medical principles identified during the medical analysis could be added to the knowledge base and the preference model, respectively. We would also like to test our approach in other medical domains. However, this would require a preliminary work by medical experts to identify the drug features involved in the recommendations, and the constitution of a knowledge base for representing the domain. The constitution of this knowledge base may be a long process: for antibiotherapy, it took several months and 5 rounds of Delphi Process. The extraction of the content of the knowledge base was not automated in the presented work, although the design of an automatic process is an interesting perspective.
It would be interesting to test a qualitative model, such as conditional preferences [44] , in addition to the quantitative preference model proposed in this paper. We would like to check whether it would allow the detection of additional inconsistencies.
Another perspective is the design of a tool based on our preference model and the knowledge base, for supporting experts during the writing of CPGs. The tool could help experts to detect inconsistencies in their recommendations before CPGs publications, but could also suggest a list of recommended antibiotics for each clinical situation. This could speed up the development process of CPGs, which is currently too long [5] .
Furthermore, these findings might be used for designing a clinical decision-support system for helping physicians to prescribe antibiotics [77] . Indeed, the preference model could be used for suggesting antibiotics when no recommendation exists in CPGs. Further works are needed to confirm this hypothesis.
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